Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Circulation|July 13, 2026
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized TrialIsabelle Mahé, Céline Chapelle, Marc Righini, et al.
Critical Reviews in Oncology/Hematology|October 6, 2009
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working groupDominique Farge, Lise Bosquet, Diana Kassab-Chahmi, et al.
Thrombosis and Haemostasis|November 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling StudyXavier Delavenne, Jean Escal, Dominique Helley, et al.
Journal of Thrombosis and Haemostasis : JTH|July 17, 2024
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center studyIsabelle Gouin-Thibault, Alexandre Mansour, Charlène Caribotti, et al.
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
Archives of Cardiovascular Diseases|July 2, 2013
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013Gilles Pernod, Pierre Albaladejo, Anne Godier, et al.
Anaesthesia, Critical Care & Pain Medicine|September 24, 2016
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015Pierre Albaladejo, Fanny Bonhomme, Normand Blais, et al.
Thrombosis and Haemostasis|April 14, 2017
The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE RegistryAlexander T Cohen, Anselm K Gitt, Rupert Bauersachs, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolismFrederikus A Klok, Emilie Presles, Cecile Tromeur, et al.
JAMA|April 29, 2015
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trialPatrick Mismetti, Silvy Laporte, Olivier Pellerin, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Circulation|July 13, 2026
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized TrialIsabelle Mahé, Céline Chapelle, Marc Righini, et al.
Critical Reviews in Oncology/Hematology|October 6, 2009
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working groupDominique Farge, Lise Bosquet, Diana Kassab-Chahmi, et al.
Thrombosis and Haemostasis|November 25, 2025
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling StudyXavier Delavenne, Jean Escal, Dominique Helley, et al.
Journal of Thrombosis and Haemostasis : JTH|July 17, 2024
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center studyIsabelle Gouin-Thibault, Alexandre Mansour, Charlène Caribotti, et al.
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
Archives of Cardiovascular Diseases|July 2, 2013
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013Gilles Pernod, Pierre Albaladejo, Anne Godier, et al.
Anaesthesia, Critical Care & Pain Medicine|September 24, 2016
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015Pierre Albaladejo, Fanny Bonhomme, Normand Blais, et al.
Thrombosis and Haemostasis|April 14, 2017
The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE RegistryAlexander T Cohen, Anselm K Gitt, Rupert Bauersachs, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolismFrederikus A Klok, Emilie Presles, Cecile Tromeur, et al.
JAMA|April 29, 2015
Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trialPatrick Mismetti, Silvy Laporte, Olivier Pellerin, et al.
Pageof 18